Strength Seen in Precision BioSciences (DTIL): Can Its 20.4% Jump Turn into More Strength?

Precision BioSciences (DTIL) shares soared 20.4% in the last trading session to close at $16. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 22.4% gain over the past four weeks.The sudden rise in the stock price can be attributed to the positive investor midset regarding the company's lead gene editing program PBGENE-HBV, currently in pre-clinical stage. Earlier this month, Precision Biosciences received feedback from the FDA an ...